Sol Gel Technologies Ltd Asset Turnover Ratio (SLGL), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Sol gel Technologies Ltd   (NASDAQ: SLGL)
 

Sol Gel Technologies Ltd Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Sol Gel Technologies Ltd asset turnover ratio, the ability of Sol Gel Technologies Ltd 's assets to generate revenue in the fourth quarter 2025, increased sequentially to 1.04 in the fourth quarter (Dec 31 2025), yet the ratio remained below the average, as SLGL's position remain challenging.

Within sector 50 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the IV Quarter 2025, to 1333, from total ranking in the third quarter 2025 at 2704.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SLGL Asset Turnover Ratio (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Asset Change -14.79 % -12.71 % -5.74 % -12.71 % -53.27 %
Y / Y Revenue Change 68.04 % - 217.71 % - 642.47 %
Asset Turnover Ratio (TTM) 1.04 - 0.76 - 0.43
SLGL's Total Ranking # 1333 # 2704 # # #
Seq. Asset Change 24.76 % -20.36 % 25.57 % -31.7 % 27.81 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 51
Healthcare Sector # 132
Overall Market # 1333

Asset Turnover Ratio Statistics
High Average Low
9.85 4.01 0.49
(Dec 31 2025)   (Dec 31 2022)




SLGL Company Profile • Back to SLGL Efficiency Comparisons • Compare SLGL Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Assets at quarter ending Dec 31 2025
Biotricity Inc   2.58 $ 15.224  Millions$ 5.910  Millions
Escalon Medical Corp   2.49 $ 12.311  Millions$ 4.943  Millions
Healthcare Services Group Inc   2.28 $ 1,837.173  Millions$ 805.929  Millions
Interpace Biosciences Inc   2.10 $ 38.130  Millions$ 18.176  Millions
Vycor Medical Inc   2.08 $ 1.863  Millions$ 0.898  Millions
Biofrontera Inc   2.07 $ 41.706  Millions$ 20.177  Millions
Integrated Biopharma Inc  2.05 $ 51.068  Millions$ 24.911  Millions
Nuo Therapeutics Inc   2.05 $ 3.218  Millions$ 1.570  Millions
P3 Health Partners Inc   2.04 $ 1,459.080  Millions$ 713.915  Millions
Edap Tms Sa  1.89 $ 166.111  Millions$ 88.085  Millions
Nature s Sunshine Products inc   1.86 $ 479.724  Millions$ 258.382  Millions
Champions Oncology Inc   1.85 $ 57.944  Millions$ 31.349  Millions
Biocryst Pharmaceuticals Inc   1.84 $ 874.837  Millions$ 474.454  Millions
Electrocore Inc   1.80 $ 31.800  Millions$ 17.670  Millions
Innovage Holding Corp   1.74 $ 915.371  Millions$ 525.304  Millions
Talkspace Inc   1.72 $ 228.871  Millions$ 132.739  Millions
International Stem Cell Corporation  1.71 $ 9.100  Millions$ 5.318  Millions
Progyny Inc   1.70 $ 1,288.484  Millions$ 757.224  Millions
Option Care Health Inc   1.66 $ 5,648.895  Millions$ 3,406.738  Millions
Privia Health Group Inc   1.64 $ 2,122.842  Millions$ 1,294.111  Millions
Iridex Corp  1.64 $ 50.474  Millions$ 30.831  Millions
Adm Tronics Unlimited Inc   1.55 $ 3.414  Millions$ 2.201  Millions
Cv Sciences Inc   1.54 $ 11.388  Millions$ 7.417  Millions
Chemed Corporation  1.53 $ 2,529.978  Millions$ 1,651.543  Millions
Kewaunee Scientific Corporation  1.53 $ 288.233  Millions$ 188.294  Millions
Koru Medical Systems Inc   1.52 $ 41.127  Millions$ 27.009  Millions
Medinotec Inc   1.51 $ 10.325  Millions$ 6.848  Millions
Marpai Inc  1.49 $ 18.099  Millions$ 12.109  Millions
Qhslab Inc   1.48 $ 2.692  Millions$ 1.821  Millions
Nephros Inc   1.46 $ 18.625  Millions$ 12.727  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.